Newsfiscal.ai
China SXT Pharmaceuticals Inc. Announces Termination of Additional Purchase Right
· Published
Article summary
China SXT Pharmaceuticals, Inc. has terminated the right of purchasers to acquire up to an additional $12 million in shares or pre-funded warrants from its October 8, 2026, registered direct offering.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…